These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9431833)

  • 1. Dose- and time-dependency of the dilator effects of the endothelin antagonist, BQ-123, in the human forearm.
    Berrazueta JR; Bhagat K; Vallance P; MacAllister RJ
    Br J Clin Pharmacol; 1997 Dec; 44(6):569-71. PubMed ID: 9431833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action of the endothelin receptor (ETA) antagonist BQ-123 on forearm blood flow in young normotensive subjects.
    Wimalasundera RC; McG Thom SA; Regan L; Hughes AD
    Clin Sci (Lond); 2002 Jun; 102(6):661-6. PubMed ID: 12049621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic ETA receptor antagonism with BQ-123 blocks ET-1 induced forearm vasoconstriction and decreases peripheral vascular resistance in healthy men.
    Spratt JC; Goddard J; Patel N; Strachan FE; Rankin AJ; Webb DJ
    Br J Pharmacol; 2001 Oct; 134(3):648-54. PubMed ID: 11588120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forearm vasoconstriction to endothelin-1 is impaired, but constriction to sarafotoxin 6c and vasodilatation to BQ-123 unaltered, in patients with essential hypertension.
    Ferro CJ; Haynes WG; Hand MF; Webb DJ
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():53S-58S. PubMed ID: 12193054
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade.
    Verhaar MC; Strachan FE; Newby DE; Cruden NL; Koomans HA; Rabelink TJ; Webb DJ
    Circulation; 1998 Mar; 97(8):752-6. PubMed ID: 9498538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelin receptor antagonism in patients with chronic heart failure.
    Love MP; Ferro CJ; Haynes WG; Plumpton C; Davenport AP; Webb DJ; McMurray JJ
    Cardiovasc Res; 2000 Jul; 47(1):166-72. PubMed ID: 10869543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced vasodilatation to endothelin antagonism in patients with compensated cirrhosis and the role of nitric oxide.
    Helmy A; Newby DE; Jalan R; Hayes PC; Webb DJ
    Gut; 2003 Mar; 52(3):410-5. PubMed ID: 12584225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin-1 and vascular tone in subjects with atherogenic risk factors.
    Nohria A; Garrett L; Johnson W; Kinlay S; Ganz P; Creager MA
    Hypertension; 2003 Jul; 42(1):43-8. PubMed ID: 12756218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered peripheral vascular responses to exogenous and endogenous endothelin-1 in patients with well-compensated cirrhosis.
    Helmy A; Jalan R; Newby DE; Johnston NR; Hayes PC; Webb DJ
    Hepatology; 2001 Apr; 33(4):826-31. PubMed ID: 11283846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased activity of endogenous endothelin in patients with type II diabetes mellitus.
    Cardillo C; Campia U; Bryant MB; Panza JA
    Circulation; 2002 Oct; 106(14):1783-7. PubMed ID: 12356630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex differences in endothelin-1-mediated vasoconstrictor tone in middle-aged and older adults.
    Stauffer BL; Westby CM; Greiner JJ; Van Guilder GP; Desouza CA
    Am J Physiol Regul Integr Comp Physiol; 2010 Feb; 298(2):R261-5. PubMed ID: 19939973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of endogenous generation of endothelin-1 to basal vascular tone.
    Haynes WG; Webb DJ
    Lancet; 1994 Sep; 344(8926):852-4. PubMed ID: 7916401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved endothelial function after endothelin receptor blockade in patients with systemic sclerosis.
    Cardillo C; Schinzari F; Melina D; Mores N; Bosello S; Peluso G; Zoli A; Ferraccioli G
    Arthritis Rheum; 2009 Jun; 60(6):1840-4. PubMed ID: 19479828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced endogenous endothelin-1-mediated vascular tone in chronic renal failure.
    Hand MF; Haynes WG; Webb DJ
    Kidney Int; 1999 Feb; 55(2):613-20. PubMed ID: 9987085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of endothelin in the increased vascular tone of patients with essential hypertension.
    Cardillo C; Kilcoyne CM; Waclawiw M; Cannon RO; Panza JA
    Hypertension; 1999 Feb; 33(2):753-8. PubMed ID: 10024340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blunted vascular response to endothelin-a receptor blockade in cyclosporine-treated lung transplant recipients.
    Silverborn M; Ambring A; Nilsson F; Friberg P; Jeppsson A
    J Heart Lung Transplant; 2005 Jun; 24(6):665-70. PubMed ID: 15949725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous endothelin-1 limits exercise-induced vasodilation in hypertensive humans.
    McEniery CM; Wilkinson IB; Jenkins DG; Webb DJ
    Hypertension; 2002 Aug; 40(2):202-6. PubMed ID: 12154114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vascular endothelin system is not overactive in normotensive hemodialysis patients.
    Büssemaker E; Passauer J; Reimann D; Schulze B; Reichel W; Gross P
    Kidney Int; 2002 Sep; 62(3):940-8. PubMed ID: 12164876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex-specific effects of cardiovascular risk factors on endothelium-dependent dilation and endothelin activity in middle-aged women and men.
    Brar V; Gill S; Cardillo C; Tesauro M; Panza JA; Campia U
    PLoS One; 2015; 10(3):e0121810. PubMed ID: 25807234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for altered vascular responses to exogenous endothelin-1 in patients with advanced cirrhosis with restoration of the normal vasoconstrictor response following successful liver transplantation.
    Vaughan RB; Angus PW; Chin-Dusting JP
    Gut; 2003 Oct; 52(10):1505-10. PubMed ID: 12970146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.